CareDx (CDNA) Tops Q4 EPS by 28c, provides guidance

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.17), $0.28 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $65.6 million versus the consensus estimate of $62.63 million.

GUIDANCE:

CareDx sees FY2024 revenue of $260-274 million, versus the consensus of $260.7 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00